These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8387101)

  • 1. Elevation of human cerebrospinal fluid clusterin concentration is associated with acute neuropathology.
    Polihronis M; Paizis K; Carter G; Sedal L; Murphy B
    J Neurol Sci; 1993 Apr; 115(2):230-3. PubMed ID: 8387101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid C9 in demyelinating disease.
    Compston DA; Morgan BP; Oleesky D; Fifield R; Campbell AK
    Neurology; 1986 Nov; 36(11):1503-6. PubMed ID: 3762967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness.
    Davies L; McLeod JG; Muir A; Hensley WJ
    Clin Exp Neurol; 1987; 24():5-10. PubMed ID: 2478320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of a single abnormal immunoglobulin band in cerebrospinal fluid electrophoresis.
    Ben-Hur T; Abramsky O; River Y
    J Neurol Sci; 1996 Mar; 136(1-2):159-61. PubMed ID: 8815164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry.
    Stoop MP; Dekker LJ; Titulaer MK; Burgers PC; Sillevis Smitt PA; Luider TM; Hintzen RQ
    Proteomics; 2008 Apr; 8(8):1576-85. PubMed ID: 18351689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid beta 2-microglobulin in neurological disorders.
    Tenhunen R; Iivanainen M; Kovanen J
    Acta Neurol Scand; 1978 Dec; 58(6):366-73. PubMed ID: 84513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A derivative of myelin-associated glycoprotein in cerebrospinal fluid of normal subjects and patients with neurological disease.
    Yanagisawa K; Quarles RH; Johnson D; Brady RO; Whitaker JN
    Ann Neurol; 1985 Oct; 18(4):464-9. PubMed ID: 2416268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoelectric focusing and isotachophoresis for investigation of CSF and serum proteins in demyelinating and infectious neurological diseases.
    Kjellin KG; Siden A
    Adv Exp Med Biol; 1978; 100():545-59. PubMed ID: 80951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J; Chonn A; Hertig S; French LE
    J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal complement activation in neurological diseases evaluated by analysis of the terminal complement complex.
    Mollnes TE; Vandvik B; Lea T; Vartdal F
    J Neurol Sci; 1987 Mar; 78(1):17-28. PubMed ID: 3572448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls.
    Rodriguez M; Wynn DR; Kimlinger TK; Katzmann JA
    Neurology; 1990 May; 40(5):855-7. PubMed ID: 2330118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis.
    Morgan BP; Campbell AK; Compston DA
    Lancet; 1984 Aug; 2(8397):251-4. PubMed ID: 6146808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF protein and cellular profiles in various stages of HIV infection related to neurological manifestations.
    Elovaara I; Iivanainen M; Valle SL; Suni J; Tervo T; Lähdevirta J
    J Neurol Sci; 1987 May; 78(3):331-42. PubMed ID: 3035107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid proteins and serum immunoglobulins. Occurrence in multiple sclerosis and other neurological diseases: comparative measurement of gamma-globulin and the IgG class.
    Fischer-Williams M; Roberts RC
    Arch Neurol; 1971 Dec; 25(6):526-34. PubMed ID: 4107216
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrospinal-fluid ciliary neurotrophic factor in neurological patients.
    Massaro AR; Soranzo C; Carnevale A
    Eur Neurol; 1997; 37(4):243-6. PubMed ID: 9208266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid immunoglobulin G in childhood. Measurement by electroimmunodiffusion.
    Nellhaus G
    Arch Neurol; 1971 May; 24(5):441-8. PubMed ID: 4995260
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of cerebrospinal fluid glycoprotein levels in the diagnosis of primary brain tumor.
    Houck JC; McBride HJ; O'Doherty DS
    Neurology; 1968 Apr; 18(4):397-402. PubMed ID: 4173448
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electro-immunodiffusion of cerebrospinal fluid proteins. Determination of 2 -HS, ceruloplasmin, - 1A - 1C , hemopexin and IgA].
    Schuller E; Allinquant B; Garcia M; Lefèvre M; Moreno P; Tompe L
    Clin Chim Acta; 1971 Jun; 33(1):5-11. PubMed ID: 4106481
    [No Abstract]   [Full Text] [Related]  

  • 19. Protein profile of human perilymph: in search of markers for the diagnosis of perilymph fistula and other inner ear disease.
    Thalmann I; Kohut RI; Ryu J; Comegys TH; Senarita M; Thalmann R
    Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 1):273-80. PubMed ID: 8084635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium and inorganic phosphate content in CSF related to blood-brain barrier function in neurological disease.
    Heipertz R; Eickhoff K; Karstens KH
    J Neurol Sci; 1979 Feb; 40(2-3):87-95. PubMed ID: 430103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.